1. Home
  2. NAVN vs ALKS Comparison

NAVN vs ALKS Comparison

Compare NAVN & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Navan Inc.

NAVN

Navan Inc.

SELL

Current Price

$27.06

Market Cap

7.0B

Sector

Technology

ML Signal

SELL

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$45.89

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAVN
ALKS
Founded
2015
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
7.6B
IPO Year
2025
2012

Fundamental Metrics

Financial Performance
Metric
NAVN
ALKS
Price
$27.06
$45.89
Analyst Decision
Strong Buy
Buy
Analyst Count
15
20
Target Price
$30.80
★ $56.21
AVG Volume (30 Days)
★ 2.2M
1.8M
Earning Date
12-14-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
$702,265,000.00
★ $1,475,899,000.00
Revenue This Year
$32.58
$23.51
Revenue Next Year
$24.21
$5.13
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 30.82
N/A
52 Week Low
$8.11
$27.00
52 Week High
$30.88
$55.67

Technical Indicators

Market Signals
Indicator
NAVN
ALKS
Relative Strength Index (RSI) 48.29 61.69
Support Level $22.15 $39.41
Resistance Level $28.08 $47.40
Average True Range (ATR) 1.01 1.56
MACD -0.08 0.47
Stochastic Oscillator 29.93 78.28

Price Performance

Historical Comparison
NAVN
ALKS

About NAVN Navan Inc.

Navan Inc is engaged in providing an end-to-end, AI-powered software platform for managing business travel and expense (T&E). The company's platform enables users to manage corporate travel bookings, payments, and expense processes, while providing tools for customers to control and optimize spending and for suppliers to access demand. Geographically, the company operates in the United States, the United Kingdom, and other countries, with the majority of its revenue generated from the United States.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: